IL152923A - Acids-5 (–4 methyl –– 1-piperazinylsulfonyl) position-converted benzoic acids in position 2 - Google Patents

Acids-5 (–4 methyl –– 1-piperazinylsulfonyl) position-converted benzoic acids in position 2

Info

Publication number
IL152923A
IL152923A IL15292399A IL15292399A IL152923A IL 152923 A IL152923 A IL 152923A IL 15292399 A IL15292399 A IL 15292399A IL 15292399 A IL15292399 A IL 15292399A IL 152923 A IL152923 A IL 152923A
Authority
IL
Israel
Prior art keywords
compound
reaction
methyl
title compound
ethyl
Prior art date
Application number
IL15292399A
Other languages
English (en)
Hebrew (he)
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10840421&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL152923(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of IL152923A publication Critical patent/IL152923A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15292399A 1998-10-12 1999-10-07 Acids-5 (–4 methyl –– 1-piperazinylsulfonyl) position-converted benzoic acids in position 2 IL152923A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9822238.3A GB9822238D0 (en) 1998-10-12 1998-10-12 Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof
IL13227399A IL132273A (en) 1998-10-12 1999-10-07 -5 [(- 4-methyl-1-piperazinylsulfonyl) -2-benazamidomethmer] -1-methyl-3-profile-H1-ferrous-5-carboxamides, their preparation and process for the preparation of sildenafil from them

Publications (1)

Publication Number Publication Date
IL152923A true IL152923A (en) 2004-02-08

Family

ID=10840421

Family Applications (11)

Application Number Title Priority Date Filing Date
IL15292399A IL152923A (en) 1998-10-12 1999-10-07 Acids-5 (–4 methyl –– 1-piperazinylsulfonyl) position-converted benzoic acids in position 2
IL15292699A IL152926A (en) 1998-10-12 1999-10-07 Process for the preparation of 11 ethyl – 4 [–3 {3 ethyl 66, 77 dihydro - 7 - oxo - 2 - (pyridylmethyl) H2 - pyrazolo [4, 3 - [d pyrimidine - 5 - ile] propoxysulfonyl} - piperazine and intermediates –4 [2 Transformed –– 5 (–4 ethyl –– 1 piperazinylsulfonyl) - benzamide] - 5 - ethyl –– 1 (–2 pyridylmethyl) - H1 - pyrazole - 3 - carboxamide for it
IL13227399A IL132273A (en) 1998-10-12 1999-10-07 -5 [(- 4-methyl-1-piperazinylsulfonyl) -2-benazamidomethmer] -1-methyl-3-profile-H1-ferrous-5-carboxamides, their preparation and process for the preparation of sildenafil from them
IL15292499A IL152924A (en) 1998-10-12 1999-10-07 Acids-5 (-4-ethyl-1-piperazinylsulfonyl) position-converted benzoic acids in position 2
IL15292799A IL152927A (en) 1998-10-12 1999-10-07 1- [3- (7,6-Dihydro-1-methyl-7-oxo-3-profile-1H-pyrazolo [3,4-d] pyrimidin-5-yl) - (Phenyl converted at position 4) Sulfonyl] -4-methyl piperazines
IL152928A IL152928A (en) 1998-10-12 1999-10-07 1 - ethyl - 4 - [3 - [3 - ethyl - 6, 7 - dihydro - 7 oxo - 2 - (2 - pyridylmethyl) - 2H - pyrazolo [4, 3 - d] pyramidine - 5 - ile] (4 - Transformed phenyl (sulfonyl) piperazines
IL15292702A IL152927A0 (en) 1998-10-12 2002-11-18 Process for preparation of pyrazolo [4,3-d] pyrimidin-7-ones and intermediates thereof
IL15292602A IL152926A0 (en) 1998-10-12 2002-11-18 Process for preparation of pyrazolo[4,3-d] pyrimidin-7-ones and intermediates thereof
IL15292402A IL152924A0 (en) 1998-10-12 2002-11-18 Process for preparation of pyrazolo[4,3-d] pyrimidin-7-ones and intermediates thereof
IL15292302A IL152923A0 (en) 1998-10-12 2002-11-18 Process for preparation of pyrazolo[4,3-d] pyrimidin-7-ones and intermediates thereof
IL15292802A IL152928A0 (en) 1998-10-12 2002-11-18 Process for preparation of pyrazolo [4,3-d] pyrimidin-7-ones and intermediates thereof

Family Applications After (10)

Application Number Title Priority Date Filing Date
IL15292699A IL152926A (en) 1998-10-12 1999-10-07 Process for the preparation of 11 ethyl – 4 [–3 {3 ethyl 66, 77 dihydro - 7 - oxo - 2 - (pyridylmethyl) H2 - pyrazolo [4, 3 - [d pyrimidine - 5 - ile] propoxysulfonyl} - piperazine and intermediates –4 [2 Transformed –– 5 (–4 ethyl –– 1 piperazinylsulfonyl) - benzamide] - 5 - ethyl –– 1 (–2 pyridylmethyl) - H1 - pyrazole - 3 - carboxamide for it
IL13227399A IL132273A (en) 1998-10-12 1999-10-07 -5 [(- 4-methyl-1-piperazinylsulfonyl) -2-benazamidomethmer] -1-methyl-3-profile-H1-ferrous-5-carboxamides, their preparation and process for the preparation of sildenafil from them
IL15292499A IL152924A (en) 1998-10-12 1999-10-07 Acids-5 (-4-ethyl-1-piperazinylsulfonyl) position-converted benzoic acids in position 2
IL15292799A IL152927A (en) 1998-10-12 1999-10-07 1- [3- (7,6-Dihydro-1-methyl-7-oxo-3-profile-1H-pyrazolo [3,4-d] pyrimidin-5-yl) - (Phenyl converted at position 4) Sulfonyl] -4-methyl piperazines
IL152928A IL152928A (en) 1998-10-12 1999-10-07 1 - ethyl - 4 - [3 - [3 - ethyl - 6, 7 - dihydro - 7 oxo - 2 - (2 - pyridylmethyl) - 2H - pyrazolo [4, 3 - d] pyramidine - 5 - ile] (4 - Transformed phenyl (sulfonyl) piperazines
IL15292702A IL152927A0 (en) 1998-10-12 2002-11-18 Process for preparation of pyrazolo [4,3-d] pyrimidin-7-ones and intermediates thereof
IL15292602A IL152926A0 (en) 1998-10-12 2002-11-18 Process for preparation of pyrazolo[4,3-d] pyrimidin-7-ones and intermediates thereof
IL15292402A IL152924A0 (en) 1998-10-12 2002-11-18 Process for preparation of pyrazolo[4,3-d] pyrimidin-7-ones and intermediates thereof
IL15292302A IL152923A0 (en) 1998-10-12 2002-11-18 Process for preparation of pyrazolo[4,3-d] pyrimidin-7-ones and intermediates thereof
IL15292802A IL152928A0 (en) 1998-10-12 2002-11-18 Process for preparation of pyrazolo [4,3-d] pyrimidin-7-ones and intermediates thereof

Country Status (49)

Country Link
US (3) US6207829B1 (es)
EP (1) EP0994115B1 (es)
JP (1) JP3721021B2 (es)
KR (1) KR100380954B1 (es)
CN (2) CN1207295C (es)
AP (1) AP1233A (es)
AR (1) AR019244A1 (es)
AT (1) ATE290003T1 (es)
AU (1) AU756463B2 (es)
BG (1) BG63205B1 (es)
BR (1) BR9905092A (es)
CA (1) CA2285733C (es)
CO (1) CO5150214A1 (es)
CR (1) CR6118A (es)
CU (1) CU22928A3 (es)
CZ (1) CZ296816B6 (es)
DE (1) DE69923906T2 (es)
DK (1) DK0994115T3 (es)
DZ (1) DZ2912A1 (es)
EA (1) EA003774B1 (es)
EE (1) EE04192B1 (es)
EG (1) EG22630A (es)
ES (1) ES2237049T3 (es)
GB (1) GB9822238D0 (es)
GE (1) GEP20022700B (es)
GT (1) GT199900172A (es)
HK (1) HK1027559A1 (es)
HR (1) HRP990318B1 (es)
HU (1) HU226162B1 (es)
ID (1) ID23351A (es)
IL (11) IL152923A (es)
IS (1) IS1951B (es)
MA (1) MA25007A1 (es)
MY (1) MY124620A (es)
NO (1) NO313700B1 (es)
OA (1) OA11165A (es)
PE (1) PE20001086A1 (es)
PL (1) PL198150B1 (es)
PT (1) PT994115E (es)
RS (1) RS49762B (es)
SG (1) SG118060A1 (es)
SI (1) SI0994115T1 (es)
SK (1) SK285215B6 (es)
TN (1) TNSN99189A1 (es)
TR (1) TR199902541A2 (es)
TW (1) TW589314B (es)
UA (1) UA66787C2 (es)
UY (1) UY25750A1 (es)
ZA (1) ZA996412B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078760A1 (fr) * 1999-06-21 2000-12-28 The Biochemical Pharmaceutical Factory Of Zhuhai Sez Procede de preparation de sildenafil, agent et procede d'obtention d'un comprime mixte a base de sildenafil et de chlorhydrate d'apomorphine
AU2001262597B2 (en) * 2000-06-22 2005-10-20 Pfizer Inc. Process for the preparation of pyrazolopyrimidinones
US6667398B2 (en) 2000-06-22 2003-12-23 Pfizer Inc Process for the preparation of pyrazolopyrimidinones
US6407259B1 (en) 2000-07-28 2002-06-18 Pfizer Inc. Process for the preparation of pyrazoles
EP1176147A1 (en) * 2000-07-28 2002-01-30 Pfizer Limited Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof
EP1176142A1 (en) * 2000-07-28 2002-01-30 Pfizer Inc. Process for the preparation of pyrazoles
PE20020394A1 (es) 2000-08-18 2002-06-21 Agouron Pharma Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
CA2469075C (en) 2001-12-20 2011-09-13 Applied Research Systems Ars Holding N.V. Pyrrolidine derivatives as prostaglandin modulators
JP4361800B2 (ja) * 2001-12-21 2009-11-11 サイトキネティックス， インコーポレイテッド 心不全を処置するための組成物および方法
EP1719772A1 (en) 2002-05-31 2006-11-08 Schering Corporation Process for preparing xanthine phosphodiesterase v inhibitors and precursors thereof
WO2004072079A1 (en) * 2003-02-11 2004-08-26 Pfizer Limited Hydrated and anhydrous sildenafil hemi-citrate compound
EP1605752B1 (en) 2003-03-27 2011-09-14 Cytokinetics, Inc. Sulfonamides for the treatment of congestive heart failure, their compositions and uses.
CN100360531C (zh) * 2003-12-18 2008-01-09 中国人民解放军军事医学科学院放射与辐射医学研究所 用于预防或治疗阳萎和性冷淡的新吡唑并嘧啶类化合物
US20070010525A1 (en) * 2005-06-27 2007-01-11 Meyer Jackson Method and compositions for modulating neuropeptide hormone secretion
NL2000291C2 (nl) * 2005-11-10 2009-02-17 Pfizer Prod Inc 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
WO2007141805A2 (en) * 2006-06-05 2007-12-13 Matrix Laboratories Limited Novel process for the preparation of sildenafil citrate
CZ308056B6 (cs) * 2015-07-20 2019-11-27 Ustav Experimentalni Botaniky Av Cr V V I 5-Substituované-7-[4-(substituované)benzyl]amino-3-isopropylpyrazolo[4,3-d]pyrimidiny, jejich použití jako antirevmatika, a farmaceutické přípravky
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
CN107759603B (zh) * 2016-08-18 2020-09-01 四川科伦药物研究院有限公司 一种杂环化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992441A (en) * 1972-12-26 1976-11-16 Pfizer Inc. Sulfamylbenzoic acids
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
IL132276A0 (en) * 1997-04-25 2001-03-19 Pfizer Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cgmp pde5) for the treatment of sexual dysfunction

Also Published As

Publication number Publication date
IL152926A0 (en) 2003-06-24
US6207829B1 (en) 2001-03-27
TR199902541A2 (xx) 2000-07-21
BR9905092A (pt) 2000-08-08
TW589314B (en) 2004-06-01
NO994943D0 (no) 1999-10-11
ES2237049T3 (es) 2005-07-16
DE69923906T2 (de) 2006-04-06
BG103794A (en) 2000-09-29
IL152924A (en) 2004-02-19
UY25750A1 (es) 2001-08-27
EG22630A (en) 2003-05-31
AP9901672A0 (en) 1999-12-31
CU22928A3 (es) 2004-02-20
IL132273A0 (en) 2001-03-19
AU756463B2 (en) 2003-01-16
SK285215B6 (sk) 2006-09-07
CR6118A (es) 2005-09-16
AU5358199A (en) 2000-04-13
IL152928A0 (en) 2003-06-24
EP0994115A3 (en) 2000-05-24
OA11165A (en) 2003-04-22
KR100380954B1 (ko) 2003-04-21
EE9900507A (et) 2000-06-15
HUP9903469A3 (en) 2000-10-30
NO994943L (no) 2000-04-13
IS5209A (is) 2000-04-13
TNSN99189A1 (fr) 2005-11-10
KR20000028987A (ko) 2000-05-25
EP0994115B1 (en) 2005-03-02
IL152924A0 (en) 2003-06-24
GB9822238D0 (en) 1998-12-09
EA199900822A3 (ru) 2000-08-28
AR019244A1 (es) 2001-12-26
AP1233A (en) 2003-12-18
EE04192B1 (et) 2003-12-15
CN1207295C (zh) 2005-06-22
IL152928A (en) 2007-07-04
GEP20022700B (en) 2002-05-27
CA2285733C (en) 2004-08-24
PT994115E (pt) 2005-06-30
NO313700B1 (no) 2002-11-18
PL198150B1 (pl) 2008-05-30
SG118060A1 (en) 2006-01-27
CO5150214A1 (es) 2002-04-29
GT199900172A (es) 2001-03-28
JP2000119273A (ja) 2000-04-25
SI0994115T1 (es) 2005-08-31
ATE290003T1 (de) 2005-03-15
US20010009962A1 (en) 2001-07-26
YU48999A (sh) 2002-06-19
HRP990318A2 (en) 2000-06-30
MY124620A (en) 2006-06-30
CN1473831A (zh) 2004-02-11
RS49762B (sr) 2008-04-04
IL152926A (en) 2004-02-19
HK1027559A1 (en) 2001-01-19
BG63205B1 (bg) 2001-06-29
CZ353299A3 (cs) 2000-05-17
JP3721021B2 (ja) 2005-11-30
HUP9903469A2 (hu) 2000-08-28
UA66787C2 (en) 2004-06-15
MA25007A1 (fr) 2000-07-01
ZA996412B (en) 2001-04-11
PL335959A1 (en) 2000-04-25
CZ296816B6 (cs) 2006-06-14
EA199900822A2 (ru) 2000-04-24
HU9903469D0 (en) 1999-12-28
EP0994115A2 (en) 2000-04-19
PE20001086A1 (es) 2000-10-18
IL152923A0 (en) 2003-06-24
IS1951B (is) 2004-10-13
IL132273A (en) 2004-06-20
CN1255497A (zh) 2000-06-07
IL152927A0 (en) 2003-06-24
SK138599A3 (en) 2000-05-16
CA2285733A1 (en) 2000-04-12
DE69923906D1 (de) 2005-04-07
DK0994115T3 (da) 2005-06-20
ID23351A (id) 2000-04-13
EA003774B1 (ru) 2003-08-28
HU226162B1 (en) 2008-05-28
HRP990318B1 (en) 2004-06-30
IL152927A (en) 2004-06-01
DZ2912A1 (fr) 2004-03-01
US20030069422A1 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
AP1233A (en) Process for preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof.
EP0812845B1 (en) Process for preparing sildenafil
EP1092720B1 (en) Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof
US3862184A (en) N-substituted-1-(arylsulfinyl and arylsulfonyl)methanesulfonamides
US3959298A (en) Process for preparing triacetonamine
MXPA99009326A (es) Procedimiento para la preparacion de pirazolo [4,3-d]pirimidin-7-onas y sus intermedios
KR20120107791A (ko) 5-(4-알킬피페라지닐술포닐페닐)-피라졸로[4,3-ｄ]피리미딘-7-온 화합물의 제조방법

Legal Events

Date Code Title Description
FF Patent granted
KB20 Patent renewed for 20 years
EXP Patent expired